Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jun;61(6):1988-1990.
doi: 10.1111/trf.16434. Epub 2021 May 26.

High-titer convalescent plasma therapy for coronavirus disease 2019 and mortality

Mario Cruciani  1 , Giulio Bongiovanni  1 , Massimo Franchini  2
Affiliations
Comment

High-titer convalescent plasma therapy for coronavirus disease 2019 and mortality

Mario Cruciani et al. Transfusion. 2021 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have disclosed no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Forest plot of a comparison of the outcome, all‐cause mortality. Data are from three randomized controlled trials using high‐titer convalescent plasma [Color figure can be viewed at wileyonlinelibrary.com]
See this image and copyright information in PMC

Comment on

References

    1. Janiaud P, Axfors C, Schmitt AM, Gloy V, et al. Association of convalescent plasma treatment with clinical outcomes in patients with COVID‐19: a systematic review and meta‐analysis. JAMA. 2021;325:1185–195. 10.1001/jama.2021.2747. - DOI - PMC - PubMed
    1. Avendano‐Solà C, Ramos‐Martinez A, Munez‐Rubio E, et al. Convalescent plasma for COVID‐19: a multicenter, randomized clinical trial. medRxiv. 2020. 10.1101/2020.08.26.20182444. - DOI
    1. Libster R, Perez Marc G, Wappner D, et al. Early high‐titer plasma therapy to prevent severe Covid‐19 in older adults. N Engl J Med. 2021;384:610–18. 10.1056/NEJMoa2033700. - DOI - PMC - PubMed
    1. Li L, ZhangW HY, et al. Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and life‐threatening COVID‐19: a randomized clinical trial. JAMA. 2021;384:619–29. 10.1001/jama.2020.10044. - DOI - PMC - PubMed
    1. Simonovich VA, Burgos Pratx LD, Scibona P, et al. A randomized trial of convalescent plasma in Covid‐19 severe pneumonia. N Engl J Med. 2020;24. 10.1056/NEJMoa2031304. - DOI - PMC - PubMed